ArticleJournal for immunotherapy of cancer2026
Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer.
Charles W Tran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.